Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter

The use of carrier cells infected with oncolytic viruses in cancer gene therapy is an attractive method because it can overcome viral immunogenicity and induce tumor immunity and significant antitumor activity. To enable human clinical trials of this treatment, acute and chronic toxicity tests must...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Katsuyuki, Shirakawa, Toshiro, Terao, Shuji, Gotoh, Akinobu, Tani, Kenzaburo, Huang, Wenlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362384/
https://www.ncbi.nlm.nih.gov/pubmed/26015963
http://dx.doi.org/10.1038/mtm.2014.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362384/
https://www.ncbi.nlm.nih.gov/pubmed/26015963
http://dx.doi.org/10.1038/mtm.2014.19

Ejemplares similares